{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:25:26Z","timestamp":1764433526617},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,6,1]]},"DOI":"10.2169\/internalmedicine.2143-23","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T22:30:07Z","timestamp":1697754607000},"page":"1603-1608","source":"Crossref","is-referenced-by-count":4,"title":["Kidney Biopsy Proven Thrombotic Microangiopathy Induced by Methamphetamine"],"prefix":"10.2169","volume":"63","author":[{"given":"Kanako","family":"Nagaoka","sequence":"first","affiliation":[{"name":"Department of Nephrology, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Katagiri","sequence":"additional","affiliation":[{"name":"Department of Nephrology, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Matsunami","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miria","family":"Chinen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurumi","family":"Seki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Fakhouri F, Zuber J, Fr\u00e9meaux-Bacchi V, et al. Haemolytic uraemic syndrome. Lancet 390: 681-696, 2017.","DOI":"10.1016\/S0140-6736(17)30062-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med 371: 654-666, 2014.","DOI":"10.1056\/NEJMra1312353"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kang E, Yoo SH, Oh D, et al. Clinical dissection of thrombotic microangiopathy. Ann Hematol 96: 1715-1726, 2017.","DOI":"10.1007\/s00277-017-3063-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bayer G, von Tokarski F, Thoreau B, et al. Etiology and outcomes of thrombotic microangiopathies. Clin J Am Soc Nephrol 14: 557-566, 2019.","DOI":"10.2215\/CJN.11470918"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Henry N, Mellaza C, Fage N, et al. Retrospective and systematic analysis of causes and outcomes of thrombotic microangiopathies in routine clinical practice: an 11-year study. Front Med (Lausanne) 8: 566678, 2021.","DOI":"10.3389\/fmed.2021.566678"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mazzierli T, Allegretta F, Maffini E, et al. Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management. Front Pharmacol 13: 1088031, 2022.","DOI":"10.3389\/fphar.2022.1088031"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pendergraft WF 3rd, Herlitz LC, Thornley-Brown D, et al. Nephrotoxic effects of common and emerging drugs of abuse. Clin J Am Soc Nephrol 9: 1996-2005, 2014.","DOI":"10.2215\/CJN.00360114"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shima N, Miyawaki I, Bando K, et al. Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat. Toxicology 287: 29-37, 2011.","DOI":"10.1016\/j.tox.2011.05.012"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Peerzada H, Gandhi JA, Guimaraes AJ, et al. Methamphetamine administration modifies leukocyte proliferation and cytokine production in murine tissues. Immunobiology 218: 1063-1068, 2013.","DOI":"10.1016\/j.imbio.2013.02.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gupta A, Kuperman M, Shah S. N-methylamphetamine (&quot;crystal meth&quot;)-associated acute renal cortical necrosis. Kidney Int Rep 3: 1473-1476, 2018.","DOI":"10.1016\/j.ekir.2018.07.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lord KC, Shenouda SK, McIlwain E, et al. Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovasc Res 87: 111-118, 2010.","DOI":"10.1093\/cvr\/cvq043"},{"key":"12","unstructured":"12. Lan KC, Lin YF, Yu FC, et al. Clinical manifestations and prognostic features of acute methamphetamine intoxication. J Formos Med Assoc 97: 528-533, 1998."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yeo KK, Wijetunga M, Ito H, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med 120: 165-171, 2007.","DOI":"10.1016\/j.amjmed.2006.01.024"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pillai S, Cesarz B, Boulware C, et al. Hypotension, severe hyperthermia (42\u00b0C), Rhabdomyolysis, and disseminated intravascular coagulation induced by lethal dose of methamphetamine. Cureus 11: e5245, 2019.","DOI":"10.7759\/cureus.5245"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Heal DJ, Smith SL, Gosden J, et al. Amphetamine, past and present - a pharmacological and clinical perspective. J Psychopharmacol 27: 479-496, 2013.","DOI":"10.1177\/0269881113482532"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Caldwell J, Dring LG, Williams RT. Metabolism of [<sup>14<\/sup>C]methamphetamine in man, the guinea pig and the rat. Biochem J 129: 11-22, 1972.","DOI":"10.1042\/bj1290011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. McIntyre IM, Nelson CL, Schaber B, et al. Antemortem and postmortem methamphetamine blood concentrations: three case reports. J Anal Toxicol 37: 386-389, 2013.","DOI":"10.1093\/jat\/bkt040"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Baradhi KM, Pathireddy S, Bose S, et al. Methamphetamine (N-methylamphetamine)-induced renal disease: underevaluated cause of end-stage renal disease (ESRD). BMJ Case Rep 12: e230288, 2019.","DOI":"10.1136\/bcr-2019-230288"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care 2: 15, 2014.","DOI":"10.1186\/2052-0492-2-15"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ohashi R, Ishii H, Naito Z, et al. Morphological spectrum of renal pathology and its correlation to clinical features in patients with disseminated intravascular coagulation: a study involving a series of 21 autopsy cases. Pathol Int 64: 443-452, 2014.","DOI":"10.1111\/pin.12192"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chamarthi G, Lee Loy J, Koratala A. Methamphetamine-induced renal pseudovasculitis: suspicion is the key. Clin Case Rep 7: 381-382, 2019.","DOI":"10.1002\/ccr3.1976"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ding J, Wang Y, Wang Z, et al. Luteolin Ameliorates Methamphetamine-Induced Podocyte Pathology by Inhibiting Tau Phosphorylation in Mice. Evid Based Complement Alternat Med 2022: 5909926, 2022.","DOI":"10.1155\/2022\/5909926"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Fowler AH, Majithia V. Ultimate mimicry: methamphetamine-induced pseudovasculitis. Am J Med 128: 364-366, 2015.","DOI":"10.1016\/j.amjmed.2014.12.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nolan AL, Jen KY. Pathologic manifestations of levamisole-adulterated cocaine exposure. Diagn Pathol 10: 48, 2015.","DOI":"10.1186\/s13000-015-0279-z"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/11\/63_2143-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T03:34:45Z","timestamp":1717212885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/11\/63_2143-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2143-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]},"article-number":"2143-23"}}